Strata Critical Medical's Q2 2026 Earnings: A Mixed Bag for Healthcare Investors Strata Critical Medical's latest earnings call has left investors with a mixed reaction, as the company reported strong growth in its clinical business but struggled to mitigate losses in its logistics segment.
The numbers look impressive on the surface – 15. 1% sequential growth in clinical revenue and cash flow generation that meets expectations. However, scratch beneath the surface, and you'll find a more nuanced story.
Strata Critical Medical's reliance on acquisitions is starting to pay off, as evidenced by its $3 billion capital deployment plan, which has seen it acquire three bolt on deals in Q2 alone.